Despite a recent 45% rally, I maintain a 'Sell' view on CVS due to its underwhelming execution record and rising leverage ...

As healthcare spending continues to rise and regulatory pressure intensifies, companies like CVS Health CVS find themselves ...

We recently published a list of the 10 Best Performing Healthcare Stocks So Far in 2025. In this article, we are going to ...

In this article, we will look at the 10 Best Performing Healthcare Stocks So Far in 2025.

CVS Health (CVS) has made an impressive comeback in 2025, with its stock soaring 45% so far this year. This sharp rebound ...

RBC Capital analyst Ben Hendrix raised the firm’s price target on CVS Health (CVS) to $74 from $58 and keeps an Outperform rating on the shares. The company is past its earnings trough with ...

Earnings have fallen but are still strong enough to meet CVS Health's dividend commitment. Management expects adjusted earnings for 2025 to land in a range between $5.75 and $6 per share. That's ...

DraftKings' Q4 financials were expectedly weak as NFL outcomes negatively affected the industry's hold percentage. Marketing expenses also returned to growth, but DraftKings showed great user ...

Stifel analyst raised price target for Twilio after Q4 results. Strong performance in Q4 boosted SMS and voice communications revenue. Get access to your new suite of high-powered trading tools ...

Your message was sent. You'll receive a response shortly. $2,548 price drop Midway through 2024, Audi overhauled its Q4 e-Tron lineup, ditching the electric compact SUV’s rear-drive base variant ...

UPS' (NYSE: UPS) recent fourth-quarter earnings report was monumental. It wasn't so much the numbers from the final quarter of 2024 as it was management outlining the strategic changes it was ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...